Back to GG GILDER GAGNON HOWE & CO LLC

NKTRNKTR
5 quarters

Position history for GGGILDER GAGNON HOWE & CO LLC's holdings in Nektar Therapeutics

GILDER GAGNON HOWE & CO LLC holds 600,873 shares of NKTR (Nektar Therapeutics), worth $41.9M as of 2026-Q2. The position was increased (+121.1% shares). NKTR represents 0.4% of GILDER GAGNON HOWE & CO LLC's portfolio.

Current Value

$41.9M

Current Shares

600,873

Total Value Change

+$41.2M

Total Shares Change

+571,971

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
600,873
+121.1%
$41.9M0.4%$69.81
56
2026-Q1
Increased
271,758
+30.5%
$19.6M0.2%$68.11
43
2025-Q4
Decreased
208,302
-7.3%
$8.8M0.1%$41.90
0
2025-Q3
Increased
224,828
+677.9%
$12.8M0.1%$58.92
54
2025-Q2
New
28,902
-
$746,8280.0%$25.76
34

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used